# Absorption of Indacaterol and Glycopyrronium From Ultibro Breezhaler

> **NCT04856098** · PHASE1 · COMPLETED · sponsor: **Orion Corporation, Orion Pharma** · enrollment: 34 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Indacaterol maleate and glycopyrronium bromide
- **DRUG:** Indacaterol maleate and glycopyrronium bromide
- **DRUG:** Indacaterol maleate and glycopyrronium bromide
- **DRUG:** Ultibro Breezhaler with oral charcoal

## Key facts

- **NCT ID:** NCT04856098
- **Lead sponsor:** Orion Corporation, Orion Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-07
- **Primary completion:** 2021-09-21
- **Final completion:** 2021-09-21
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2021-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04856098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04856098, "Absorption of Indacaterol and Glycopyrronium From Ultibro Breezhaler". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04856098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*